![](/img/cover-not-exists.png)
Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study
Gopal, Ajay K., Schuster, Stephen J., Fowler, Nathan H., Trotman, Judith, Hess, Georg, Hou, Jing-Zhou, Yacoub, Abdulraheem, Lill, Michael, Martin, Peter, Vitolo, Umberto, Spencer, Andrew, Radford, JohVolume:
36
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2017.76.8853
Date:
August, 2018
File:
PDF, 683 KB
2018